Glucagon in prevention and abolition of ouabain-induced ventricular tachycardia in normokalemic and hypokalemic dogs.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004032:Diet; D004071:Digitalis Glycosides / Q000633:toxicity; D004285:Dogs; D005260:Female; D005934:Glucagon / Q000494:pharmacology / Q000627:therapeutic use*; D006327:Heart Block / Q000139:chemically induced; D006852:Hydrochlorothiazide; D007008:Hypokalemia / Q000503:physiopathology*; D008297:Male; D009206:Myocardium / Q000378:metabolism; D010042:Ouabain / Q000037:antagonists & inhibitors*; D010919:Placebos; D011188:Potassium / Q000378:metabolism; D012965:Sodium Chloride; D013610:Tachycardia / Q000139:chemically induced / Q000517:prevention & control*; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D010919:Placebos; D006852:Hydrochlorothiazide; D012965:Sodium Chloride; D010042:Ouabain; D005934:Glucagon; D011188:Potassium